Filing Details
- Accession Number:
- 0001209191-17-006519
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-31 20:31:18
- Reporting Period:
- 2017-01-27
- Filing Date:
- 2017-01-31
- Accepted Time:
- 2017-01-31 20:31:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1513818 | Versartis Inc. | VSAR | Pharmaceutical Preparations (2834) | 264106690 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1638380 | Shane Ward | C/O Versartis, Inc. 4200 Bohannon Dr., Suite 250 Menlo Park CA 94025 | Svp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-01-27 | 20,600 | $0.00 | 39,865 | No | 4 | A | Direct | |
Common Stock | Disposition | 2017-01-30 | 1,474 | $13.85 | 38,391 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2017-01-27 | 46,200 | $0.00 | 46,200 | $14.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
46,200 | 2027-01-26 | No | 4 | A | Direct |
Footnotes
- Represents the grant of Restricted Stock Units that vest as follows: 25% of the shares subject to the award vest on each of the first, second, third and fourth anniversaries of the date of grant, respectively, subject to the officer's continuous service on each applicable vesting date.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.
- 1/48th of the shares subject to the option become exercisable monthly measured from the date of grant.